সিঙ্গাপুর - ইংরেজি - HSA (Health Sciences Authority)

angeion medical international pte. ltd. - general hospital - the solero microwave tissue ablation (mta) system and accessories are indicated for the ablation of soft tissue during open, laparoscopic, or percutaneous procedures. the solero mta system is not intended for cardiac use.

সিঙ্গাপুর - ইংরেজি - HSA (Health Sciences Authority)

angeion medical international pte. ltd. - cardiovascular - the abluminus sirolimus eluting coronary stent system is indicated for improving luminal diameter in patients, including those with diabetes mellitus, acute myocardial infarction, symptomatic heart disease, stable angina, unstable angina or documented silent ischemia due to atherosclerotic lesions in native coronary arteries with reference diameter 2.25mm to 5.00mm and lesions of length ≤48 mm.

সিঙ্গাপুর - ইংরেজি - HSA (Health Sciences Authority)

angeion medical international pte. ltd. - radiology / imaging - the ready-box contrast media warmer is intended to warm contrast media to approximately body temperature before injection.

সিঙ্গাপুর - ইংরেজি - HSA (Health Sciences Authority)

angeion medical international pte. ltd. - general & plastic surgery - the nanoknife system is a medical device for cell electroporation. electroporation is a phenomenon that occurs in cell membranes as cells are exposed to an electrical field of sufficiently high intensity. the electric field acts as a physical stimulus bringing about alterations in cell membranes that result in increased permeability.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - hydralazine hydrochloride, quantity: 20 mg - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide; propylene glycol - hypertensive crises, especially during late pregnancy (pre-eclampsia and eclampsia).

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - bethanechol chloride, quantity: 10 mg - tablet, uncoated - excipient ingredients: erythrosine; magnesium stearate; wheat starch; amaranth; lactose monohydrate; acacia; hydrogenated vegetable oil - acute post-operative and postpartum non-obstructive urinary retension, and neurogenic atony of the urinary bladder with retension. bethanechol has no clinically significant nicotinic stimulant activity.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - thiopental sodium, quantity: 0.5 g - injection, powder for - excipient ingredients: - indications as at 08 dec 1993 : pentothal may be used : 1. as the sole anaesthetic agent for brief surgical procedures; 2. for the induction of anaesthesia prior to the administration of other anaesthetic agents; 3. for the short-term control of condvulsive states; 4. to supplement regional anaesthesia or low potency agents such as nitrous oxide.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - caspofungin -

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - caspofungin -

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - itraconazole, quantity: 50 mg - capsule - excipient ingredients: silicon dioxide; magnesium stearate; sodium starch glycollate type a; hypromellose phthalate; gelatin; brilliant blue fcf; titanium dioxide; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - superficial mycoses: lozanoc is indicated, if external treatment is not effective or not appropriate, for the treatment of the following fungal infections: dermatomycoses (e.g. tinea corporis, tinea cruris, tinea pedis, tinea manus, tinea unguium) and pityriasis versicolor. systemic mycoses: lozanoc is indicated for the treatment of systemic mycoses, such as candidiasis, aspergillosis, and histoplasmosis. consideration should be given to official guidance on the appropriate use of antimycotic agents, and to the discussion of the pharmacodynamic properties (see pharmacology).